search
Back to results

Cutibacterium Acnes: Triple Prevention in Shoulder Operations (C3PO)

Primary Purpose

Post-Operative Wound Infection, Surgical Site Infection

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Subcutaneous disinfection
Benzoyl peroxide preparation
Sponsored by
Clinique Générale dAnnecy
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Post-Operative Wound Infection focused on measuring Cutibacterium Acnes, Prevention, Benzoyl peroxide, Subcutaneous disinfection, Surgical site infection, Pre-operative disinfection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients with an indication for all types of surgery at the shoulder joint, acromioclavicular joint, or clavicle, including arthroscopic and open surgery. Exclusion Criteria: Previous shoulder surgery, history of shoulder infection, antibiotic treatment in the last 6 weeks, allergy or hypersensitivity to one of the disinfecting agents, and patients with laboratory values consistent with a current infection (C-reactive protein, erythrocyte sedimentation rate, leukocyte count).

Sites / Locations

  • Clinique Générale d'Annecy

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Experimental

Arm Label

Control/Single prevention

Double prevention

Triple prevention

Arm Description

Standard pre-operative cutaneous disinfection using iodine.

Pre-operative cutaneous and subcutaneous disinfection using iodine.

Pre-operative cutaneous and subcutaneous disinfection using iodine and preparation of the skin with benzoyl peroxide in the days prior to surgery.

Outcomes

Primary Outcome Measures

Cutibacterium Acnes positivity
Cultures taken during surgery positive for Cutibacterium Acnes

Secondary Outcome Measures

Culture positivity with other bacteria
Cultures taken during surgery positive for any type of bacteria
Adherence to pre-operative protocol
Completeness of the pre-operative skin preparation protocol as reported by participants the morning of the intervention

Full Information

First Posted
January 18, 2023
Last Updated
January 18, 2023
Sponsor
Clinique Générale dAnnecy
Collaborators
Centre Hospitalier Annecy Genevois
search

1. Study Identification

Unique Protocol Identification Number
NCT05701475
Brief Title
Cutibacterium Acnes: Triple Prevention in Shoulder Operations
Acronym
C3PO
Official Title
Triple Prevention Against Cutibacterium Acnes Using Benzoyl Peroxide Preparation in Addition to Pre-operative Cutaneous and Subcutaneous Iodine in Shoulder Surgery; a Single-blinded, Randomized, Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
February 2023 (Anticipated)
Primary Completion Date
October 2023 (Anticipated)
Study Completion Date
October 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Clinique Générale dAnnecy
Collaborators
Centre Hospitalier Annecy Genevois

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Patients planned for shoulder surgery will be identified and contacted for participation. After informed consent is provided, patients will be randomised into one of three groups: pre-operative cutaneous disinfection with iodine (control group), pre-operative cutaneous and subcutaneous disinfection with iodine (double prevention), and pre-operative cutaneous and subcutaneous disinfection with iodine combined with a skin preparation protocol with benzoyl peroxide gel in the days prior to surgery (triple prevention). Bacterial cultures will be collected during surgery of the surgical field and tissue layers. Culture positivity for Cutibacterium Acnes will be compared between the groups as a primary outcome.
Detailed Description
Eligible patients will be contacted for participation (see Eligibility Criteria). If subjects meet the inclusion criteria, patients will receive information regarding the study outline, associated risks, and subject rights. Informed consent must be freely given, specific, unambiguous, and may be withdrawn at any time. Subjects must be legally capable of providing consent. Consent will be and recorded in writing and stored for the duration of the study. The target for inclusion was set at 52 patients in each group, of each group 26 will be arthroscopic and 26 open surgery. Patients will be divided into three groups of equal size: Triple-prevention: Benzoyl peroxide at home, subcutaneous iodine, and cutaneous iodine. Double-prevention: Cutaneous and subcutaneous iodine. Single-prevention (control group): cutaneous iodine. Simple block randomisation will be used to prevent chronological bias and ensure equal group size. Treatments will be allocated with a 1:1:1 ratio using a block size of 12. Randomisation will be stratified by open or arthroscopic surgery to ensure an equal number in all three groups (3x2x26 patients) Random treatment allocation numbers will be generated and blinded, to be revealed after inclusion. Benzoyl peroxide: Patients will be instructed to apply and rub in a 5-cm strip of 5% benzoyl peroxide gel to the shoulder on dry skin in the morning and evening 2 days prior to surgery, 1 day before surgery, and a fifth time in the morning on the day of surgery. Cutaneous iodine: Standard pre-operative preparation including cutaneous disinfection with alcoholic iodine, sterile drapes. Subcutaneous iodine: Open surgery: after incision down to the fascia of the muscle layer, preparation of the whole subcutaneous layer with povidone-iodine solution will be performed and left acting during 60 seconds before full aspiration and lavage in order to not have swabs drained in povidone-iode (as it could continue to act as antiseptic during culture). For arthroscopic procedures the disinfection and swab collection protocol will be performed when creating the first portal. Bacterial culture swabs (n=9) will be taken during surgery from the patients' skin (before disinfection with iodine), subcutaneous tissue (after disinfection if randomised for subcutaneous disinfection), muscular layer, intra-articular/layer of the intervention (for example in case of clavicle surgery from the clavicle), surgeon's glove, outside scalpel, inside scalpel, and the retractors. For the swabs in the operative field, the applicable field is to be swabbed fully for 3 seconds. Each surgeon will follow the clear swab instructions from the microbiologist in order to obtain reliable cultures. Cultures will be analysed by the hospital's medical microbiological laboratory following standard protocol including a standard incubation time of 14 days. Treatment arm will be blinded for the laboratory employees. Culture positivity between the groups will be analysed using chi-square tests for each culture location. In addition, a two-way ANOVA test will be performed to assess total number of positive cultures per patient. Furthermore, logistic regression models will be used to adjust for several potential confounding factors depending on the number of positive tests in the sample.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-Operative Wound Infection, Surgical Site Infection
Keywords
Cutibacterium Acnes, Prevention, Benzoyl peroxide, Subcutaneous disinfection, Surgical site infection, Pre-operative disinfection

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomised controlled trial
Masking
Outcomes Assessor
Masking Description
Since the disinfection protocol has to be performed by the patient and care provider, this can not be blinded. However, the laboratory staff will not know which treatment arm the patient was allocated to when assessing the bacterial cultures.
Allocation
Randomized
Enrollment
156 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control/Single prevention
Arm Type
No Intervention
Arm Description
Standard pre-operative cutaneous disinfection using iodine.
Arm Title
Double prevention
Arm Type
Experimental
Arm Description
Pre-operative cutaneous and subcutaneous disinfection using iodine.
Arm Title
Triple prevention
Arm Type
Experimental
Arm Description
Pre-operative cutaneous and subcutaneous disinfection using iodine and preparation of the skin with benzoyl peroxide in the days prior to surgery.
Intervention Type
Procedure
Intervention Name(s)
Subcutaneous disinfection
Intervention Description
After incision, the subcutaneous tissue will be disinfected for 60 seconds using iodine before continuing the surgical approach.
Intervention Type
Procedure
Intervention Name(s)
Benzoyl peroxide preparation
Intervention Description
In the days prior to surgery, the skin will be prepared using Benzoyl Peroxide gel according to a standardised protocol.
Primary Outcome Measure Information:
Title
Cutibacterium Acnes positivity
Description
Cultures taken during surgery positive for Cutibacterium Acnes
Time Frame
14 days
Secondary Outcome Measure Information:
Title
Culture positivity with other bacteria
Description
Cultures taken during surgery positive for any type of bacteria
Time Frame
14 days
Title
Adherence to pre-operative protocol
Description
Completeness of the pre-operative skin preparation protocol as reported by participants the morning of the intervention
Time Frame
1 day
Other Pre-specified Outcome Measures:
Title
Adverse reaction to Benzoyl Peroxide
Description
Adverse reactions of any type to Benzoyl Peroxide reported by participants
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with an indication for all types of surgery at the shoulder joint, acromioclavicular joint, or clavicle, including arthroscopic and open surgery. Exclusion Criteria: Previous shoulder surgery, history of shoulder infection, antibiotic treatment in the last 6 weeks, allergy or hypersensitivity to one of the disinfecting agents, and patients with laboratory values consistent with a current infection (C-reactive protein, erythrocyte sedimentation rate, leukocyte count).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Geert A Buijze, MD, PhD
Phone
+33450330950
Email
gabuijze@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Lydie Reisenthel
Phone
+33450330950
Email
secretary@alps-surgery-institute.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Geert A Buijze, MD, PhD
Organizational Affiliation
Clinique Générale d'Annecy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinique Générale d'Annecy
City
Annecy
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34804207
Citation
Moore NF, Batten TJ, Hutton CE, White WJ, Smith CD. The management of the shoulder skin microbiome (Cutibacterium acnes) in the context of shoulder surgery: a review of the current literature. Shoulder Elbow. 2021 Oct;13(6):592-599. doi: 10.1177/1758573220945226. Epub 2020 Jul 27.
Results Reference
background
PubMed Identifier
33421560
Citation
Moor BK, Leger B, Steffen V, Troillet N, Emonet S, Gallusser N. Subcutaneous tissue disinfection significantly reduces Cutibacterium acnes burden in primary open shoulder surgery. J Shoulder Elbow Surg. 2021 Jul;30(7):1537-1543. doi: 10.1016/j.jse.2020.11.018. Epub 2021 Jan 6.
Results Reference
background
PubMed Identifier
32939469
Citation
Kaveeshwar S, Duvall G, Jones DL, O'Hara NN, Klein A, Diedrich AM, Kolakowski L, Lai JK, Hasan SA, Henn RF 3rd, Gilotra MN. Risk factors for increased shoulder Cutibacterium acnes burden. JSES Int. 2020 Jun 3;4(3):464-469. doi: 10.1016/j.jseint.2020.04.020. eCollection 2020 Sep.
Results Reference
background
PubMed Identifier
32741563
Citation
Hudek R, Brobeil A, Bruggemann H, Sommer F, Gattenlohner S, Gohlke F. Cutibacterium acnes is an intracellular and intra-articular commensal of the human shoulder joint. J Shoulder Elbow Surg. 2021 Jan;30(1):16-26. doi: 10.1016/j.jse.2020.04.020. Epub 2020 Jun 9.
Results Reference
background
PubMed Identifier
28065868
Citation
Lavergne V, Malo M, Gaudelli C, Laprade M, Leduc S, Laflamme P, Rouleau DM. Clinical impact of positive Propionibacterium acnes cultures in orthopedic surgery. Orthop Traumatol Surg Res. 2017 Apr;103(2):307-314. doi: 10.1016/j.otsr.2016.12.005. Epub 2017 Jan 5.
Results Reference
background
PubMed Identifier
31229329
Citation
Chalmers PN, Beck L, Stertz I, Tashjian RZ. Hydrogen peroxide skin preparation reduces Cutibacterium acnes in shoulder arthroplasty: a prospective, blinded, controlled trial. J Shoulder Elbow Surg. 2019 Aug;28(8):1554-1561. doi: 10.1016/j.jse.2019.03.038. Epub 2019 Jun 20.
Results Reference
background
PubMed Identifier
32197761
Citation
Singh AM, Sethi PM, Romeo AA, Anakwenze OA, Abboud JA, Namdari S. Strategies to decolonize the shoulder of Cutibacterium acnes: a review of the literature. J Shoulder Elbow Surg. 2020 Apr;29(4):660-666. doi: 10.1016/j.jse.2019.11.037.
Results Reference
background
PubMed Identifier
28479255
Citation
Dizay HH, Lau DG, Nottage WM. Benzoyl peroxide and clindamycin topical skin preparation decreases Propionibacterium acnes colonization in shoulder arthroscopy. J Shoulder Elbow Surg. 2017 Jul;26(7):1190-1195. doi: 10.1016/j.jse.2017.03.003. Epub 2017 May 4.
Results Reference
background
PubMed Identifier
30054245
Citation
Kolakowski L, Lai JK, Duvall GT, Jauregui JJ, Dubina AG, Jones DL, Williams KM, Hasan SA, Henn RF 3rd, Gilotra MN. Neer Award 2018: Benzoyl peroxide effectively decreases preoperative Cutibacterium acnes shoulder burden: a prospective randomized controlled trial. J Shoulder Elbow Surg. 2018 Sep;27(9):1539-1544. doi: 10.1016/j.jse.2018.06.012. Epub 2018 Jul 24.
Results Reference
background
PubMed Identifier
26067191
Citation
Sabetta JR, Rana VP, Vadasdi KB, Greene RT, Cunningham JG, Miller SR, Sethi PM. Efficacy of topical benzoyl peroxide on the reduction of Propionibacterium acnes during shoulder surgery. J Shoulder Elbow Surg. 2015 Jul;24(7):995-1004. doi: 10.1016/j.jse.2015.04.003.
Results Reference
background
PubMed Identifier
29609999
Citation
Scheer VM, Bergman Jungestrom M, Lerm M, Serrander L, Kalen A. Topical benzoyl peroxide application on the shoulder reduces Propionibacterium acnes: a randomized study. J Shoulder Elbow Surg. 2018 Jun;27(6):957-961. doi: 10.1016/j.jse.2018.02.038. Epub 2018 Mar 30.
Results Reference
background
PubMed Identifier
32197765
Citation
van Diek FM, Pruijn N, Spijkers KM, Mulder B, Kosse NM, Dorrestijn O. The presence of Cutibacterium acnes on the skin of the shoulder after the use of benzoyl peroxide: a placebo-controlled, double-blinded, randomized trial. J Shoulder Elbow Surg. 2020 Apr;29(4):768-774. doi: 10.1016/j.jse.2019.11.027.
Results Reference
background
PubMed Identifier
33545336
Citation
Scheer VM, Jungestrom MB, Serrander L, Kalen A, Scheer JH. Benzoyl peroxide treatment decreases Cutibacterium acnes in shoulder surgery, from skin incision until wound closure. J Shoulder Elbow Surg. 2021 Jun;30(6):1316-1323. doi: 10.1016/j.jse.2020.12.019. Epub 2021 Feb 3.
Results Reference
background
PubMed Identifier
32385554
Citation
Hsu JE, Whitson AJ, Woodhead BM, Napierala MA, Gong D, Matsen FA 3rd. Randomized controlled trial of chlorhexidine wash versus benzoyl peroxide soap for home surgical preparation: neither is effective in removing Cutibacterium from the skin of shoulder arthroplasty patients. Int Orthop. 2020 Jul;44(7):1325-1329. doi: 10.1007/s00264-020-04594-x. Epub 2020 May 8.
Results Reference
background
PubMed Identifier
36067940
Citation
Green N, Jordan RW, Maclean S, D'Alessandro P, MacDonald PB, Malik SS. Preoperative topical benzoyl peroxide treatment is effective in reducing Cutibacterium acnes in shoulder surgery: a systematic review. J Shoulder Elbow Surg. 2023 Jan;32(1):213-222. doi: 10.1016/j.jse.2022.07.019. Epub 2022 Sep 5.
Results Reference
background
PubMed Identifier
31839392
Citation
Stull JD, Nicholson TA, Davis DE, Namdari S. Addition of 3% hydrogen peroxide to standard skin preparation reduces Cutibacterium acnes-positive culture rate in shoulder surgery: a prospective randomized controlled trial. J Shoulder Elbow Surg. 2020 Feb;29(2):212-216. doi: 10.1016/j.jse.2019.09.038. Epub 2019 Dec 13.
Results Reference
background
PubMed Identifier
29870447
Citation
Rao AJ, Chalmers PN, Cvetanovich GL, O'Brien MC, Newgren JM, Cole BJ, Verma NN, Nicholson GP, Romeo AA. Preoperative Doxycycline Does Not Reduce Propionibacterium acnes in Shoulder Arthroplasty. J Bone Joint Surg Am. 2018 Jun 6;100(11):958-964. doi: 10.2106/JBJS.17.00584.
Results Reference
background
PubMed Identifier
28734717
Citation
Namdari S, Nicholson T, Parvizi J, Ramsey M. Preoperative doxycycline does not decolonize Propionibacterium acnes from the skin of the shoulder: a randomized controlled trial. J Shoulder Elbow Surg. 2017 Sep;26(9):1495-1499. doi: 10.1016/j.jse.2017.06.039. Epub 2017 Jul 19.
Results Reference
background
PubMed Identifier
31938858
Citation
Matsen FA, Whitson AJ, Hsu JE. While home chlorhexidine washes prior to shoulder surgery lower skin loads of most bacteria, they are not effective against Cutibacterium (Propionibacterium). Int Orthop. 2020 Mar;44(3):531-534. doi: 10.1007/s00264-019-04477-w. Epub 2020 Jan 14.
Results Reference
background
PubMed Identifier
30936948
Citation
MacLean SBM, Phadnis J, Ling CM, Bain GI. Application of dermal chlorhexidine antisepsis is ineffective at reducing Proprionibacterium acnes colonization in shoulder surgery. Shoulder Elbow. 2019 Apr;11(2):98-105. doi: 10.1177/1758573218755570. Epub 2018 Jan 30.
Results Reference
background
PubMed Identifier
31676186
Citation
Duvall G, Kaveeshwar S, Sood A, Klein A, Williams K, Kolakowski L, Lai J, Enobun B, Hasan SA, Henn RF 3rd, Gilotra MN. Benzoyl peroxide use transiently decreases Cutibacterium acnes load on the shoulder. J Shoulder Elbow Surg. 2020 Apr;29(4):794-798. doi: 10.1016/j.jse.2019.06.026. Epub 2019 Oct 31.
Results Reference
background

Learn more about this trial

Cutibacterium Acnes: Triple Prevention in Shoulder Operations

We'll reach out to this number within 24 hrs